Recombinant Human Antithrombin (ATryn®) in the Treatment of Patients With DIC Associated With Severe Sepsis This study is currently recruiting patients. Verified by LEO Pharma July 2007 Phase II Last Updated: July 23, 2007 <A HREF="http://clinicaltrials.gov/ct/show/NCT00506519?order=3" target="_blank">http://clinicaltrials.gov/ct/show/NCT00506519?order=3</A>